| Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice. | |
| | |
MedLine Citation:
|
PMID: 20880029 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND AND PURPOSE: There is growing evidence that the cannabinoid CB(1) receptor antagonist, rimonabant (SR141716) exerts potential anti-proliferative and anti-inflammatory actions. Here, we have assessed the effects of rimonabant in vitro in murine immortalized keratinocytes and in vivo by assaying the topical anti-inflammatory activity. EXPERIMENTAL APPROACH: Cell viability and death in a keratinocyte cell line (C5N cells) were measured by Trypan blue exclusion assay and cytotoxicity by sulphorhodamine B test. Cell cycle progression was assessed by flow cytometry and the expression of apoptotic and anti-apoptotic markers, cyclins, pathways of signal transduction and CB1 receptor levels were evaluated by Western blot. The topical anti-inflammatory properties of rimonabant were analysed by inhibition of croton oil-induced ear dermatitis in mice. KEY RESULTS: Rimonabant reduced cell viability and induced apoptosis as shown by the enhanced number of cells in the subG0 phase of the cell cycle, the expression of Bax and reduced levels of Bcl-2 and X-inhibitor of apoptosis protein. In addition, reduced levels of phosphorylated serine/threonine protein kinase Akt and nuclear factor-kappa B were detected associated with regulation of total nuclear factor-kappa B and inhibitor of kappa B-α, phosphorylated inhibitor of kappa B-α, cyclins D1, E and A. In croton oil-induced ear dermatitis, rimonabant significantly reduced oedema and leukocyte infiltrate. CONCLUSIONS AND IMPLICATIONS: Rimonabant reduced cell viability, inducing cell death in keratinocytes and decreased croton oil-induced ear dermatitis. Our findings suggest a potential application of rimonabant as a topical anti-inflammatory drug. We did not assess the involvement of CB(1) receptors in these effects of rimonabant. |
| | |
Authors:
|
Anna Maria Malfitano; Silvio Sosa; Chiara Laezza; Marco De Bortoli; Aurelia Tubaro; Maurizio Bifulco |
Related Documents
:
|
16466619 - Mechanisms of immune-mediated skin diseases: an overview. 19492999 - Topical application of green and white tea extracts provides protection from solar-simu... 15503089 - Cyclosporin a-induced hair growth in mice is associated with inhibition of hair follicl... 20406189 - Skin protection against uva-induced iron damage by multiantioxidants and iron chelating... 2524279 - The role of suppressor factors in the regulation of immune responses by ultraviolet rad... 8608339 - The renin-angiotensin-system in the skin. evidence for its presence and possible functi... 18155359 - Pmn-mediated immune reactions against eimeria bovis. 21440619 - High glucose induces apoptosis in embryonic neural progenitor cells by a pathway involv... 9282829 - Cytokine profiles of stimulated blood lymphocytes in asthmatic and healthy adolescents ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: British journal of pharmacology Volume: 162 ISSN: 1476-5381 ISO Abbreviation: Br. J. Pharmacol. Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2010-12-07 Completed Date: 2011-04-05 Revised Date: 2012-01-02 |
Medline Journal Info:
|
Nlm Unique ID: 7502536 Medline TA: Br J Pharmacol Country: England |
Other Details:
|
Languages: eng Pagination: 84-93 Citation Subset: IM |
Copyright Information:
|
© 2010 The Authors. British Journal of Pharmacology © 2010 The British Pharmacological Society. |
Affiliation:
|
Department of Pharmaceutical Sciences, University of Salerno, Fisciano, Salerno, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Topical Animals Anti-Inflammatory Agents / pharmacology* Apoptosis / drug effects* Cell Cycle / drug effects Cell Division / drug effects Cell Line Keratinocytes / cytology, drug effects*, metabolism Mice Piperidines / pharmacology* Pyrazoles / pharmacology* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Inflammatory Agents; 0/Piperidines; 0/Pyrazoles; 158681-13-1/rimonabant |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: An increase in caries rate or an increase in access to care: data show mixed results.
Next Document: Caries experience of adults attending private and public dental clinics in Australia.